Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
K151046Substantially Equivalent

illumigene HSV 1&2 DNA Amplification Assay, illumigene HSV 1&2 External Control Kit, illumipro-10

Meridian Bioscience Inc, Cincinnati OH / Traditional, Substantially Equivalent

K151046 is the FDA 510(k) clearance record for illumigene HSV 1&2 DNA Amplification Assay, illumigene HSV 1&2 External Control Kit, illumipro-10, a class II device, cleared for Meridian Bioscience, Inc. on under FDA product code PGI (Herpes Virus (Vzv, Hsv1, Hsv2), Dna Detection Assay For Cutaneous And Mucocutaneous Lesion Samples). FDA's definition for product code PGI reads: "For the qualitative detection and differentiation of VZV, HSV1, HSV2- DNA in cutaneous and mucocutaneous lesion samples from symptomatic patients. The assay is not intended for use with cerebral spinal fluid". FDA records list 38 510(k) clearances for Meridian Bioscience, Inc., from to . As of , FDA records show no recalls naming K151046.

Clearance record

Decision date
Received
(88 days to decision)
Product code
PGI Herpes Virus (Vzv, Hsv1, Hsv2), Dna Detection Assay For Cutaneous And Mucocutaneous Lesion Samples
Regulation
21 CFR 866.3309
Device class
Class II
Review panel
Microbiology
Applicant
Meridian Bioscience, Inc. 3471 River Hills Dr., Cincinnati OH
510(k) summary
Summary PDF
Third party review
No

Clearances, product code PGI

Trailing 12 months

FDA records hold no clearances under product code PGI in the trailing twelve months.

FDA records show no clearances under product code PGI in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code PGI, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260